Bayabao, Alaizah D.
HRN: 21-95-47 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2022
MUPIROCIN 2%, 15G (TUBE)
10/28/2022
11/04/2022
IV
Topical
Tid
Pcap D, T/c Parapneumonic Effusion Vs Tb
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes